It is estimated that about 40% of people with type 2 diabetes will develop chronic kidney disease.
Santo Domingo.- Finefenone is a new drug focused on slowing the progression of chronic kidney disease in type 2 diabetic patients at high cardiovascular risk.
this new drug Inhibits inflammation, reduces fibrosis and lowers albumin levels (a protein whose presence in urine is evidence of kidney disease) in patients with chronic kidney disease and type 2 diabetes.
“Finerenone is an indicated therapy for type 2 diabetic adults with chronic kidney disease. What it does is block the action of certain hormones (steroids) produced by the body that can cause damage to the heart and kidneys, inflammation in these organs and Fibrosis can block the processes”, explained Dr. Mauricio Chávez, Cardiorenal Medical Advisor at Bayer.
The doctor added that finerenone “may reduce the risk of worsening of kidney disease and the need for hospitalization for heart failure, as well as reduce the risk of cardiovascular events.”
About chronic kidney disease in people with diabetes
Chronic kidney disease is a very serious complication of diabetes in patients with type 2 diabetes and its early detection is important to treat it and give a quality life to the patient. There are no symptoms or signs in its early stages.
“Kidney damage is silent; Normally the patient will not feel anything. Many times the patient goes to their doctor when they notice some symptoms and this can happen when the patient starts to accumulate fluid; That is, his face, eyelids, hands are swollen, he has difficulty urinating or he urinates little, he has fatigue, nausea, vomiting, persistent itching of the skin. These are signs that appear when the disease is already very advanced”, explained Dr. Chávez.
Chronic kidney disease in people with diabetes that is not treated in time and can get worse enough and lead to eventual kidney failure; The patient will then need periodic dialysis (a treatment for end-stage renal failure to remove harmful substances from the blood when the kidneys cannot do this, or receive a kidney transplant in order to survive. As we said, Pablo 40 % of people with diabetes will develop chronic kidney disease, and if so, their life expectancy will be reduced by about 16 years. Causes.
In the Dominican Republic it is estimated that the incidence of type 2 diabetes is 12%; Moreover, about 35% were unaware that they had diabetes. These data come from the study “Characterization of Type 2 Diabetes Mellitus in the Dominican Republic” conducted by the National Institute of Diabetes, Endocrinology and Nutrition (INDEN).
Bayer is a multinational company with core competencies in the bioscientific areas of health and food. With its products and services, the company aspires to be of benefit to humanity and to protect the environment by helping to find solutions to the main challenges posed by the continued aging and growth of the world’s population.